Target intelligence / Profile preview

DNA N6-methyladenine modification regulators (6mA regulators)

Target
6mA regulators
Molecular classification
Epigenetic modification, Enzyme, Phosphatase regulatory subunit, Other
01

Overview

DNA N6-methyladenine (6mA) modification regulators are a class of proteins responsible for the dynamic addition (writers), removal (erasers), and recognition (readers) of the 6mA epigenetic mark on deoxyadenosine. While 6mA is a well-established epigenetic modification in prokaryotes, its role in eukaryotes has recently gained attention, particularly regarding its influence on gene expression and chromatin structure in human cancers (Xiao et al., 2018). Specific proteins such as Protein Phosphatase 1 Regulatory Subunit 3A (PPP1R3A) and Autophagy Related 3 (ATG3) have been identified in bioinformatic signatures as key regulators or correlates of 6mA dynamics in malignancies like colorectal cancer, where they are associated with tumor progression and patient prognosis (Li et al., 2021). These regulators often possess dual roles; for example, ATG3 is a critical E2-like enzyme in the autophagy pathway, while PPP1R3A regulates glycogen synthesis, suggesting that 6mA-mediated epigenetic control may be integrated with fundamental cellular metabolic and homeostatic processes (Xie et al., 2018). Targeting these regulators offers a novel therapeutic avenue for modulating oncogenic signaling, though the multi-functional nature of proteins like ATG3 and PPP1R3A presents significant challenges for achieving therapeutic specificity without disrupting vital cellular functions.

Other names
6mA DNA modification regulatorsN6-methyladenine regulatorsDNA 6mA writers, erasers, and readersN6-methyldeoxyadenosine regulators
02

Mechanism of action

Modulation of DNA N6-methyladenine levels to regulate the expression of oncogenes or tumor suppressors through changes in chromatin accessibility and transcriptional activity.

03

Biological functions

Epigenetic regulationDNA methylationGene expression regulationAutophagyGlycogen metabolism
04

Disease associations

CancerColorectal cancerGlioblastomaGastric cancer
05

Safety considerations

Off-target effects on essential autophagy processes (via ATG3)Disruption of systemic glycogen metabolism (via PPP1R3A)Global epigenetic instabilityPotential for widespread transcriptional dysregulation
06

Biomarkers

Genomic 6mA levelsPPP1R3A expression levelsATG3 expression levelsALKBH1 expression levels

Beyond the preview

Go deeper on DNA N6-methyladenine modification regulators (6mA regulators).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA N6-methyladenine modification regulators (6mA regulators).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call